Tweenvest Stocks

The Korea Fund, Inc. (NYSE: KF)

Financials · Capital Markets · US

$63.75

-7.37% today · +101.5% 1Y

The Korea Fund, Inc. (NYSE: KF) operates in the Capital Markets industry within the Financials sector. The company is valued at $265.09M.

Over the last twelve months the share price has gained 101.5%, trading between 30.99 and 81.94.

Tweenvest scores The Korea Fund, Inc. across four factors: quality 55/100, value 48/100, dividend 100/100. Its strongest factor is dividend.

KF price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$265.09M
Revenue (TTM)
$2.28M
P/E
1.09
EPS
58.40
Dividend yield
2.16%
Beta (5Y)
1.64
52-week high
$81.94
52-week low
$30.99
Avg volume (3M)
—
Shares outstanding
4.16M
Employees
—
Next earnings
—

About The Korea Fund, Inc.

The Korea Fund, Inc. operates as a closed-end investment vehicle, managed by Allianz Global Investors U.S. LLC. Its primary objective is to allocate capital to publicly traded companies within the dynamic equity markets of Korea. The fund strategically diversifies its holdings across various sectors, with a particular emphasis on identifying growth-oriented companies. Its investment approach hinges on rigorous fundamental analysis, employing a bottom-up stock selection methodology. This involves meticulously scrutinizing factors such as price-to-earnings ratios, dividend yields, and earnings-per-share growth to construct its portfolio. Performance is evaluated relative to the MSCI Korea 25/50 Index. Furthermore, it incorporates insights from 'Grassroots Research' to inform its investment decisions. Established on August 29, 1984, The Korea Fund, Inc. maintains its domicile in the United States.

ISIN
US5006342092
Founded
1984
Listed since
Aug 22, 1984
Exchange
New York Stock Exchange
Currency
USD
CompanyMarket capPriceDay
PT Pacific Strategic Financial TbkIDX: APIC$266.97MRp406.00+1.50%
Whitefield Income LimitedASX: WHI$266.88MAU$1.24+0.81%
United Bankers OyjHLSE: UNITED$266.05M€21.40+1.42%
Spirits Capital CorporationOTCPK: SSCC$265.86M$——
Oaktree Acquisition Corp. III Life SciencesNasdaqGM: OACC$264.26M$10.75-0.09%
EUWAX AktiengesellschaftDB: EUX$263.53M€45.70+1.33%
Drugs Made In America Acquisition Corp.NasdaqGM: DMAA$263.40M$10.85-0.37%
Kazakhstan Stock Exchange Joint-Stock CompanyKAS: KASE$263.39MKZT111,000.00-1.76%

Browse every Capital Markets company →

Figures last refreshed Oct 11, 2026.